BYSI
NASDAQ
US
BeyondSpring, Inc. - Ordinary Shares
$1.73
▲ +$0.02
(+0.88%)
Vol 2K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$67.0M
ROE
-133.1%
Margin
-726.2%
D/E
5.88
Beta
0.44
52W
$1–$3
Wall Street Consensus
7 analysts · Jun 20243
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2021 | $-0.27 | $-0.24 | +$0.03 |
| Sep 2021 | $-0.38 | $-0.47 | $-0.09 |
| Jun 2021 | $-0.33 | $-0.49 | $-0.16 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$2.1M | -$1.7M | $4.5M | -$1.8M | -$1.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -133.1% | -133.1% | -133.1% | -133.1% | -133.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -726.2% | -726.2% | -726.2% | -726.2% | -726.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 |
| Current Ratio | 2.19 | 2.49 | 2.19 | 2.19 | 2.19 | 1.89 |
Key Ratios
ROA (TTM)
-30.3%
P/S (TTM)
67.03
P/B
6.6
EPS (TTM)
$-0.25
52W High
$3.44
52W Low
$0.98
$0.98
52-Week Range
$3.44
Financial Health
Free Cash Flow
-$4.2M
Net Debt
-$12.1M
Cash
$12.5M
Total Debt
$406K
As of Sep 30, 2025
How does BYSI compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BYSI valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
67.0
▲
422%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
6.6
▲
170%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BYSI profitability vs Biotechnology peers
ROE
-133.1%
▼
98%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-726.2%
▼
153%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-30.3%
▲
35%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
BYSI financial health vs Biotechnology peers
D/E ratio
5.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼
57%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.4
▼
55%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
BYSI fundamentals radar
BYSI
Peer median
Industry
BYSI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BYSI vs peers: key metrics
Top Holders
Top 5: 14.45%Decheng Capital LLC
9.43%
$6.1M
Vanguard Group Inc
1.88%
$1.2M
Blackrock Inc.
1.66%
$1.1M
Geode Capital Management, L…
0.91%
$590K
State Street Corporation
0.57%
$370K
As of Dec 31, 2025
Latest News
No related news yet